Company Overview and News

3
Emmerson Resources reveals early stage copper-gold discovery in New South Wales

2018-06-14 proactiveinvestors.com.au
Emmerson Resources Limited (ASX:ERM) has received encouraging results from the first pass fieldwork at the Whatling Hill copper-gold prospect within its Fifield project in New South Wales.
NCMGF NCM NCMGY EVN AMI RRL 3993 CAHPF ERM RGRNF EMMRF

0
China goes all out to secure lithium, cobalt supplies – key to dominating the world electric car market

2018-06-03 scmp
Cobalt, however, faces bigger challenges than lithium, which has seen bigger price gains over the past two years amid lack of certainty over new supplies, stockpiling and traders taking speculative positions
3993

1
Ex-Louis Dreyfus metal unit changes name to IXM

2018-05-29 reuters
**Louis Dreyfus Company Metals says changed its name with immediate effect to “IXM” following takeover by NCCL Natural Resources Investment Fund.
3993

0
Should You Invest in the VanEck Vectors Rare Earth/Strategic Metals ETF (REMX)?

2018-05-11 zacks
Looking for broad exposure to the Materials - Rare Earth/Lithium segment of the U.S. equity market? You should consider the VanEck Vectors Rare Earth/Strategic Metals ETF (REMX - Free Report) , a passively managed exchange traded fund launched on 10/27/2010.
FSTA AMZA 3993

20
Ivanhoe Mines issues 2018 first quarter financial results and review of exploration and development activities

2018-05-08 globenewswire
TORONTO, May 08, 2018 (GLOBE NEWSWIRE) -- Ivanhoe Mines (TSX:IVN) (OTCQX:IVPAF) today announced its financial results for the first quarter ended March 31, 2018. All figures are in U.S. dollars unless otherwise stated. Ivanhoe Mines is a Canadian mining company focused on advancing its three mine-development projects in Southern Africa: The Platreef platinum-palladium-nickel-copper-gold discovery in South Africa; the Kamoa-Kakula copper discovery in the Democratic Republic of Congo (DRC); and the extensive upgrading of the historic Kipushi zinc-copper-lead-germanium mine, also in the DRC.
ITOCY RGORF MALRY IVN AMFW AU 3993 GOLD RRS ZIJMY MIN GOLD AULGF IVPAF AMFW ITOCF 2899 AMCBF AGG MALRF ZIJMF

172
China’s Carmakers Want to Dominate World’s Next Era of Driving - Bloomberg

2018-04-26 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
TMOAY TM TYT 3993 GOOG NVDA TOYOF DDAIF TMOAF IT VLKAF AN GOOGL 0700 7203 TOM2 MSFT BIDU

0
Canada's First Cobalt eager for more after U.S. Cobalt buy

2018-04-25 reuters
LONDON (Reuters) - Canada’s First Cobalt, which has just bought another cobalt developer, is keen for more acquisitions to accelerate bringing on production to meet North American demand, a senior company official said.
3993

13
Mining industry hopeful that D.R. Congo mining-code issues can be resolved

2018-04-23 globenewswire
KINSHASA, Democratic Republic of Congo, April 23, 2018 (GLOBE NEWSWIRE) -- Ivanhoe Mines (TSX:IVN) (OTCQX:IVPAF) announced that a joint statement was issued earlier today by a group of international mining companies, including Ivanhoe Mines, addressing ongoing negotiations concerning the Democratic Republic of Congo’s mining code.
RGORF IVN AU 3993 GOLD RRS ZIJMY GOLD AULGF IVPAF 2899 AGG ZIJMF

13
Mining Industry Hopeful On DRC Code Issues

2018-04-23 accesswire
KINSHASA, DRC / ACCESSWIRE / April 23, 2018 / Mining industry representatives* in the Democratic Republic of Congo are hopeful that their current engagement with Civil Society, a member of the Mining Code Revision Tri-Partite group and other key interest groups will contribute to a better understanding of certain issues that need to be addressed before the country's new mining code is implemented.
RGORF IVN AU 3993 GOLD RRS ZIJMY GOLD AULGF IVPAF 2899 AGG ZIJMF

2
Chinese Firms Have Never Been This Reliant on Foreign Revenue - Bloomberg

2018-04-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
1800 3993 IVZ

13
Randgold Resources - GOLD - Mining code proposal submitted to DRC government

2018-03-29 accesswire
KINSHASA, DRC / ACCESSWIRE / March 29, 2018 / Mining industry representatives* in the Democratic Republic of Congo have submitted a formal proposal to the country's Ministry of Mines that is designed to address concerns about the recently revised mining code as well as the government's revenue needs.
RGORF IVN AU 3993 GOLD RRS ZIJMY GOLD AULGF IVPAF 2899 AGG ZIJMF

0
Miners launch bid to avert punishing new taxes in DRC

2018-03-25 telegraph.co.uk
Some of the world’s biggest mining companies are set to open negotiations with the Democratic Republic of Congo on Monday over a new mining code that could impose tough new conditions and higher royalties on the metals they produce.
IVPAF 3993 IVN

208
Cobalt Miners News For The Month Of March 2018

2018-03-25 seekingalpha
Cobalt spot price news - Spot prices rise 18.7% in the past month as inventory falls. The cobalt spot price is now over USD 40/lb, and approaching USD 100,000/tonne.
SIE PIO PANRF HAV PAN KBGCF MCR FCX ECSIF IGO VIC BAR AOU HIG PLM.RT TAKRF UMICF SNNAF FQM LGI MCRZF BXTMF MLX PSDNF POM CDU RGARF CHK VLKAF MCRZY FTMDF KAT RER CSSQF GMRSF CZN PGM GBLEF NZRIF AZS GLCNF DLE HBNRF MEI PIONF CZI AMSLF HMI POS AUZ RNX GME AAPL FQVLF AQR MBL PTNUF FT HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF KATFF MLXEF OZMLF PLM S CNJ AZRMF HLPCF BHP OZL ARV

9
UPDATE 1-Congo rejects mining industry proposal to soften new code

2018-03-23 reuters
KINSHASA, March 23 (Reuters) - Democratic Republic of Congo’s mines minister rejected a proposal by mining companies on Friday to soften some provisions in a new mining code in exchange for higher royalties.
AULGF AU 3993 AGG

0
CORRECTED-Congo govt to meet to implement new mining code

2018-03-21 reuters
KINSHASA (Reuters) - Democratic Republic of Congo said on Tuesday it would open negotiations with mining companies on Wednesday about implementing a new mining code that hikes taxes and royalties.
3993

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...